Study finds, Visual and Anatomic Outcomes of Patients with P
A Study was conducted to analyse the long-term anatomic and visual outcomes of patients with peripapillary pachychoroid syndrome (PPS), a recently described entity in the pachychoroid disease spectrum.

This study included patients from several retina centres worldwide. Visual acuity (VA), retinal thickness and choroidal thickness at baseline, 6 months and final follow-up were assessed. Temporal trends in VA and anatomic characteristics were evaluated. Visual and anatomic outcomes in eyes that were observed versus those that were treated were analysed.

--56 eyes of 35 patients were included. Median VA was 20/36 at baseline and remained stable through follow-up.

--Retinal thickness significantly decreased subfoveally, 1.5 mm nasal to the fovea and 3.0 mm nasal to the fovea corresponding to areas of increased thickening at baseline.

--Choroidal thickness significantly decreased subfoveally and 1.5 mm nasal to the fovea.

--43 eyes were treated with modalities including antivascular endothelial growth factor injection, photodynamic therapy, and others.

--VA remained stable in treated eyes over follow-up.

--An isolated peripapillary fluid pocket in the outer nuclear layer was characteristic of PPS.

Conclusively, patients with PPS had less choroidal thickening and less retinal oedema throughout the course of the disease. While some patients reported vision loss, the overall visual outcome was favorable, regardless of retinal or choroidal thickening trends.